• The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical...
    5 KB (373 words) - 02:19, 24 January 2024
  • Thumbnail for Pfizer–BioNTech COVID-19 vaccine
    Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech...
    260 KB (22,082 words) - 05:55, 13 September 2024
  • A COVID19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus...
    200 KB (22,796 words) - 05:34, 12 September 2024
  • Thumbnail for Janssen COVID-19 vaccine
    The Janssen COVID19 vaccine, sold under the brand name Jcovden, is a COVID19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,...
    141 KB (11,328 words) - 07:32, 10 August 2024
  • Thumbnail for Sanofi–Translate Bio COVID-19 vaccine
    Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate Bio. The development...
    5 KB (284 words) - 12:28, 25 August 2023
  • Thumbnail for Novavax COVID-19 vaccine
    The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the...
    73 KB (5,473 words) - 01:56, 17 September 2024
  • Thumbnail for Moderna COVID-19 vaccine
    The Moderna COVID19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National...
    176 KB (13,684 words) - 05:20, 13 September 2024
  • Thumbnail for Oxford–AstraZeneca COVID-19 vaccine
    Oxford–AstraZeneca COVID19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was...
    214 KB (17,080 words) - 22:39, 12 September 2024
  • Thumbnail for Sanofi–GSK COVID-19 vaccine
    Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID19 vaccine...
    19 KB (1,426 words) - 20:52, 3 September 2024
  • Thumbnail for History of COVID-19 vaccine development
    an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration...
    122 KB (11,033 words) - 22:07, 17 July 2024
  • Thumbnail for Deployment of COVID-19 vaccines
    53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose. While 4.19 million...
    156 KB (13,915 words) - 23:28, 12 August 2024
  • Thumbnail for MRNA vaccine
    humoral immunity, and lack of interaction with the genomic DNA. While some messenger RNA vaccines, such as the Pfizer–BioNTech COVID-19 vaccine, have the...
    77 KB (7,879 words) - 16:49, 14 July 2024
  • Thumbnail for COVID-19 vaccine clinical research
    COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy...
    95 KB (18,965 words) - 23:35, 15 September 2024
  • Thumbnail for Sinopharm BIBP COVID-19 vaccine
    COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed...
    90 KB (8,570 words) - 16:40, 27 January 2024
  • Thumbnail for Sputnik V COVID-19 vaccine
    Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed...
    154 KB (13,880 words) - 03:06, 18 August 2024
  • Thumbnail for Stemirna COVID-19 vaccine
    Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical...
    3 KB (103 words) - 03:06, 12 October 2023
  • Thumbnail for CureVac COVID-19 vaccine
    The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness...
    19 KB (1,571 words) - 07:31, 10 May 2024
  • Thumbnail for Walvax COVID-19 vaccine
    originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences...
    14 KB (1,441 words) - 21:06, 14 October 2023
  • Thumbnail for Vaxart COVID-19 vaccine
    Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of...
    2 KB (98 words) - 04:31, 28 August 2023
  • Thumbnail for COVID-19 vaccine misinformation and hesitancy
    immune system responds to vaccination, and debates over the development and distribution of COVID-19 vaccines. Additionally, stories such as COVID-19...
    132 KB (12,883 words) - 20:49, 30 August 2024
  • Thumbnail for MVC COVID-19 vaccine
    MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,...
    15 KB (1,455 words) - 14:15, 9 March 2024
  • Thumbnail for Embolic and thrombotic events after COVID-19 vaccination
    Oxford–AstraZeneca COVID19 vaccine (AZD1222) during the COVID19 pandemic. It was subsequently also described in the Janssen COVID19 vaccine (Johnson & Johnson)...
    53 KB (5,176 words) - 01:55, 16 July 2024
  • Thumbnail for Vaccine passports during the COVID-19 pandemic
    and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health...
    92 KB (8,779 words) - 05:08, 19 August 2024
  • Thumbnail for Inovio COVID-19 vaccine
    Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence...
    9 KB (880 words) - 23:57, 16 June 2024
  • authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one...
    322 KB (19,558 words) - 03:33, 16 September 2024
  • Thumbnail for COVID-19 vaccine hesitancy in the United States
    the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy...
    40 KB (3,771 words) - 01:07, 31 August 2024
  • Thumbnail for Chinese Academy of Medical Sciences COVID-19 vaccine
    Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute...
    4 KB (182 words) - 14:22, 24 August 2023
  • Thumbnail for COVI-VAC (U.S. COVID-19 vaccine)
    COVI-VAC (codenamed CDX-005) is a COVID-19 vaccine developed by Codagenix, Inc. In December 2020, COVI-VAC started a Phase I clinical trial, involving...
    6 KB (391 words) - 00:08, 16 August 2024
  • Thumbnail for Endemic COVID-19
    it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot immediately be...
    19 KB (2,299 words) - 15:10, 23 August 2024
  • Thumbnail for West China Hospital COVID-19 vaccine
    West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by West China Hospital. In August 2020, WestVac Biopharma started phase...
    4 KB (289 words) - 01:19, 13 September 2024